Crescent Capital BDC (CCAP)
(Delayed Data from NSDQ)
$17.17 USD
+0.09 (0.53%)
Updated Apr 19, 2024 04:00 PM ET
After-Market: $17.15 -0.02 (-0.12%) 7:56 PM ET
2-Buy of 5 2
B Value B Growth D Momentum B VGM
Income Statements
Fiscal Year end for Crescent Capital BDC, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 184 | 117 | 94 | 77 | 53 |
Cost Of Goods | 59 | 32 | 20 | 15 | 13 |
Gross Profit | 125 | 85 | 74 | 62 | 40 |
Selling & Adminstrative & Depr. & Amort Expenses | 42 | 31 | 18 | 11 | 8 |
Income After Depreciation & Amortization | 84 | 54 | 56 | 50 | 32 |
Non-Operating Income | 0 | 6 | -6 | 0 | 0 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | 84 | 60 | 50 | 50 | 32 |
Income Taxes | 1 | 0 | 2 | 1 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 1 | -44 | 36 | 5 | -2 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 84 | 16 | 84 | 55 | 29 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 84 | 16 | 84 | 55 | 29 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 79 | 48 | 47 | 47 | 30 |
Depreciation & Amortization (Cash Flow) | -5 | -5 | -9 | -4 | -2 |
Income After Depreciation & Amortization | 84 | 54 | 56 | 50 | 32 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 35.93 | 30.89 | 28.48 | 27.68 | 17.35 |
Diluted EPS Before Non-Recurring Items | 2.30 | 1.93 | 1.67 | 1.80 | 1.82 |
Diluted Net EPS (GAAP) | 2.33 | 0.50 | 2.94 | 1.98 | 1.69 |
Fiscal Year end for Crescent Capital BDC, Inc falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 49.96 | 48.15 | 46.74 | 39.28 |
Cost Of Goods | NA | 15.72 | 15.38 | 15.27 | 12.37 |
Gross Profit | NA | 34.24 | 32.77 | 31.47 | 26.91 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 11.07 | 10.70 | 10.56 | 9.22 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 23.17 | 22.07 | 20.91 | 17.69 |
Non-Operating Income | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | NA | 23.17 | 22.07 | 20.91 | 17.69 |
Income Taxes | NA | 0.42 | 0.35 | 0.34 | 0.20 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 8.11 | 0.90 | 2.01 | -9.72 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | 30.86 | 22.62 | 22.58 | 7.78 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | 30.86 | 22.62 | 22.58 | 7.78 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 37.23 | 37.06 | 37.06 | 32.47 |
Diluted EPS Before Non-Recurring Items | NA | 0.61 | 0.59 | 0.56 | 0.54 |
Diluted Net EPS (GAAP) | NA | 0.87 | 0.61 | 0.61 | 0.24 |